98 related articles for article (PubMed ID: 15729363)
1. Haplotype analysis of the preprotachykinin-1 (TAC1) gene in multiple sclerosis.
Cunningham S; Patterson CC; McDonnell G; Hawkins S; Vandenbroeck K
Genes Immun; 2005 May; 6(3):265-70. PubMed ID: 15729363
[TBL] [Abstract][Full Text] [Related]
2. The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosis.
Cunningham S; O'Doherty C; Patterson C; McDonnell G; Hawkins S; Marrosu MG; Vandenbroeck K
J Neuroimmunol; 2007 Feb; 183(1-2):208-13. PubMed ID: 17175032
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 7q21-22 and multiple sclerosis: evidence for a genetic susceptibility effect in vicinity to the protachykinin-1 gene.
Vandenbroeck K; Fiten P; Heggarty S; Goris A; Cocco E; Hawkins SA; Graham CA; Marrosu MG; Opdenakker G
J Neuroimmunol; 2002 Apr; 125(1-2):141-8. PubMed ID: 11960650
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations.
Suppiah V; Goris A; Alloza I; Heggarty S; Dubois B; Carton H; Antigüedad A; Mendibe M; McDonnell G; Droogan A; Hawkins S; Graham C; Vandenbroeck K
Int J Immunogenet; 2005 Dec; 32(6):383-8. PubMed ID: 16313303
[TBL] [Abstract][Full Text] [Related]
5. Analysis of IL4R haplotypes in predisposition to multiple sclerosis.
Mirel DB; Barcellos LF; Wang J; Hauser SL; Oksenberg JR; Erlich HA
Genes Immun; 2004 Mar; 5(2):138-41. PubMed ID: 14712310
[TBL] [Abstract][Full Text] [Related]
6. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
[TBL] [Abstract][Full Text] [Related]
7. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
Stoevring B; Frederiksen JL; Christiansen M
Clin Chim Acta; 2007 Jan; 375(1-2):57-62. PubMed ID: 17010329
[TBL] [Abstract][Full Text] [Related]
8. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis.
Galimberti D; Scalabrini D; Fenoglio C; De Riz M; Comi C; Venturelli E; Cortini F; Piola M; Leone M; Dianzani U; D'Alfonso S; Monaco F; Bresolin N; Scarpini E
J Neurol Sci; 2008 Apr; 267(1-2):86-90. PubMed ID: 17967467
[TBL] [Abstract][Full Text] [Related]
10. Analyses of a MS-associated haplotype encompassing the CCL3 gene.
Vyshkina T; Kalman B
J Neuroimmunol; 2006 Jul; 176(1-2):216-8. PubMed ID: 16712957
[TBL] [Abstract][Full Text] [Related]
11. NOS2A as a candidate gene in Relapsing-Remitting Multiple Sclerosis: a haplotype study using selected subsets of single nucleotide polymorphisms.
Manna I; Liguori M; Valentino P; Vena L; Condino F; Nisticò R; Di Palma G; Quattrone A; Gambardella A
J Neurol Sci; 2011 May; 304(1-2):75-7. PubMed ID: 21376344
[TBL] [Abstract][Full Text] [Related]
12. CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland.
Heggarty S; Suppiah V; Silversides J; O'doherty C; Droogan A; McDonnell G; Hawkins S; Graham C; Vandenbroeck K
J Neuroimmunol; 2007 Jul; 187(1-2):187-91. PubMed ID: 17524498
[TBL] [Abstract][Full Text] [Related]
13. Linkage disequilibrium analyses within chromosome 19p in multiple sclerosis.
Vyshkina T; Kalman B
Mult Scler; 2008 May; 14(4):433-9. PubMed ID: 18208878
[TBL] [Abstract][Full Text] [Related]
14. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
[TBL] [Abstract][Full Text] [Related]
15. Association between Synapsin III gene promoter polymorphisms and multiple sclerosis.
Liguori M; Cittadella R; Manna I; Valentino P; La Russa A; Serra P; Trojano M; Messina D; Ruscica F; Andreoli V; Romeo N; Livrea P; Quattrone A
J Neurol; 2004 Feb; 251(2):165-70. PubMed ID: 14991350
[TBL] [Abstract][Full Text] [Related]
16. Tachykinin 1 (TAC1) gene SNPs and haplotypes with autism: a case-control study.
Marui T; Funatogawa I; Koishi S; Yamamoto K; Matsumoto H; Hashimoto O; Nanba E; Nishida H; Sugiyama T; Kasai K; Watanabe K; Kano Y; Kato N; Sasaki T
Brain Dev; 2007 Sep; 29(8):510-3. PubMed ID: 17376622
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers.
Grossman I; Avidan N; Singer C; Goldstaub D; Hayardeny L; Eyal E; Ben-Asher E; Paperna T; Pe'er I; Lancet D; Beckmann JS; Miller A
Pharmacogenet Genomics; 2007 Aug; 17(8):657-66. PubMed ID: 17622942
[TBL] [Abstract][Full Text] [Related]
18. Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients.
Otaegui D; Zuriarrain O; Castillo-Triviño T; Aransay A; Ruíz-Martinez J; Olaskoaga J; Marti-Masso J; Lopez de Munain A
Mult Scler; 2009 Jan; 15(1):124-8. PubMed ID: 18755822
[TBL] [Abstract][Full Text] [Related]
19. Profile of cytokine gene polymorphisms in Iranian multiple sclerosis patients.
Amirzargar A; Khosravi F; Dianat S; Hushmand F; Maryousef P; Foroushani AR; Lotfi J; Nikbin B
Mult Scler; 2007 Mar; 13(2):253-5. PubMed ID: 17439892
[TBL] [Abstract][Full Text] [Related]
20. Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis?
Sidoti A; Antognelli C; Rinaldi C; D'Angelo R; Dattola V; Girlanda P; Talesa V; Amato A
Mult Scler; 2007 May; 13(4):446-53. PubMed ID: 17463067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
